The present invention provides stable oral pharmaceutical compositions of Dabigatran etexilate mesylate and its process for the preparation of pharmaceutical composition.

The present invention relates to an improved process for the preparation of Rifaximin. More particularly the present invention relates to the preparation of amorphous form of Rifaximin.

A process for the preparation of Enantiomerically pure Pregabalin comprising;a)reacting racemic Pregabalin [(±)-3-(Aminomethyl)-5-methyl hexanoic acid] of formula II with S-(+)-mandelic acid of formula III in the presence of water to obtain diastereomeric salt, S-(+)-3- aminomethyl-5-methyl hexanoic acid S-mandelic...

A process for the preparation of Itopride HC1 comprising;a)reaction of 4-hydroxy benzaldehyde of formula II with methane sulfonyl halide to give 4-formylphenyl methane sulfonate of formula III,b)reacting the obtained product of step a) of formula III for catalytic hydrogenation with Raney nickel in presence of metha...

The present invention relates to a topical pharmaceutical composition comprising Luliconazole or its pharmaceutically acceptable salts thereof. Further the present invention relates to topical compositions are free of chelating agents and a process for the preparation of said pharmaceutical composition. ...

TITLE: "ORAL PHARMACEUTICAL COMPOSITION OF DABIGATRAN ETEXILATE MESYLATE" The present invention provides stable oral pharmaceutical compositions of Dabigatran etexilate mesylate comprising seal coated pellets is drug loading with Dabigatran etexilate mesylate in a solution of binder and processes for the preparatio...

ABSTRACT TITLE: ORAL PHARMACEUTICAL COMPOSITION OF OBETICHOLIC ACID. The present invention relates to an oral pharmaceutical composition comprising solid dosage form of Obeticholic acid tablets and the composition is suitable for use in the treatment of primary biliary cholangitis (PBC) in combination with ursodeo...

The present invention relates to a process of preparing a pharmaceutical solid oral dosage form of Rivaroxaban. The solid composition is used for prophylaxis of venous thromboembolic disorders, stroke and systemic embolisms and for prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism. ...

ABSTRACT TITLE: PHARMACEUTICAL COMPOSITION OF PRASUGREL AND ASPIRIN. The present invention relates to an oral pharmaceutical composition comprising solid dosage form of Prasugrel and Aspirin tablets in hard gelatin capsules. The composition is suitable for use in the treatment of percutaneous Coronary intervention...

ABSTRACT TITLE: ORAL COMPOSITION OF RIVAROXABAN. The present invention relates to a process of preparing an oral pharmaceutical dosage form of an oxazolidinone derivative compound, Rivaroxaban its solvates, hydrates and/or pharmaceutically acceptable salts with one or more pharmaceutical acceptable excipients. ...

PHARMACEUTICAL COMPOSITIONS COMPRISING PIRFENIDONE The present invention is related to a pharmaceutical composition comprising pirfenidone wherein, the composition comprises an immediate release component and an extended release component. Methods of making such extended release pirfenidone compositions are disclos...

The present invention is related to a pharmaceutical composition comprising Ticagrelor and its preparation thereof. The present invention further relates to a pharmaceutical composition of Ticagrelor or a pharmaceutically acceptable salt thereof wherein Hypromellose 5 CPS is used as binder in an amount of 1 to 2.9 %...

ABSTRACT “PHARMACEUTICAL COMPOSITION OF MOLNUPIRAVIR” The present invention relates to a pharmaceutical composition, methods for making pharmaceutical formulations comprising Molnupiravir or pharmaceutically acceptable salt or derivatives thereof and one or more pharmaceutically acceptable excipient. The present...

The present invention relates to an oral pharmaceutical composition comprising Nirmatrelvir or its pharmaceutically acceptable salt thereof in combination with ritonavir and one or more pharmaceutical acceptable excipients. The present invention further relates to methods of preparing and administering such pharmace...

The present invention relates to an oral pharmaceutical composition comprising Nirmatrelvir or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients having reduced particle size. The present invention further relates to methods of preparing and administering such pharmaceuti...

The present invention relates to a pharmaceutical composition comprising fixed dose combinations of a Linagliptin or its pharmaceutically acceptable salt thereof and Metformin or its pharmaceutically acceptable salt thereof where in the Linagliptin composition is stabilized by using a stabilizing agent sufficient to...

The present invention relates to sustained release formulations of Pirfenidone. Particularly, the present invention relates to 1200mg sustained release oral formulations of Pirfenidone or pharmaceutically acceptable salts thereof and processes for preparing such formulations. Further invention also discloses methods...

The present invention provides stable oral pharmaceutical compositions of Dabigatran etexilate mesylate comprising seal coated pellets is drug loading with Dabigatran etexilate mesylate in a solution of binder and processes for the preparation of said compositions.

The present invention relates to a solid oral pharmaceutical composition comprising Brexpiprazole or its pharmaceutical acceptable salts thereof and a binder (Especially, Hypromellose (Methocel E3 premium). The present invention provides a solid oral pharmaceutical composition of Brexpiprazole with desirable formula...

TITLE: ORAL PHARMACEUTICAL COMPOSITION OF DAPAGLIFLOZIN” The present invention relates to a solid oral pharmaceutical composition comprising Dapagliflozin or its pharmaceutically acceptable salts, the composition of Dapagliflozin is prepared by dissolved drug in the granulation fluid and granulated with other pharm...

The present invention relates to a process of preparing a stable pharmaceutical composition of Rivaroxaban by avoiding hydrophilic binding agent. The solid composition is used for prophylaxis of venous thromboembolic disorders, stroke and systemic embolisms and for prevention of recurrent deep vein thrombosis (DVT) ...

TITLE: “PHARMACEUTICAL COMPOSITION OF SAFINAMIDE” The present invention relates to a process of preparing an oral pharmaceutical composition comprising Safinamide or pharmeutically acceptable salt thereof, having particle size (D90) less than 100µm. The present invention further relates to methods of preparing and ...

ABSTRACT “STABLE PHARMACEUTICAL COMPOSITIONS OF ELAGOLIX” The present invention relates to stable pharmaceutical composition comprising Elagolix or its pharmaceutical acceptable salt thereof and one or more pharmaceutical acceptable excipients. The present invention further relates to methods of preparing and ...

“STABLE PHARMACEUTICAL COMPOSITIONS OF BEMPEDOIC ACID” The present invention relates to stable pharmaceutical composition comprising Bempedoic acid or its pharmaceutical acceptable salt thereof and one or more pharmaceutical acceptable excipients. The present invention further relates to methods of preparing and ...

ABSTRACT “STABLE PHARMACEUTICAL COMPOSITIONS OF EDOXABAN” The present invention relates to stable pharmaceutical composition comprising Edoxaban or its pharmaceutical acceptable salt thereof and one or more pharmaceutical acceptable excipients; wherein the present invention is devoid of sugar alcohols. The pre...

The present invention relates to stable pharmaceutical composition comprising Molnupiravir or its pharmaceutical acceptable salt thereof and one or more pharmaceutical acceptable excipients; wherein composition comprises substantially free from impurities such as Dimethyl dioxol impurity (I), Acetyl impurity (II) an...

A topical composition containing Ozenoxacin and suitable carrier to manufacture a cream or lotion which are intended to be used for the treatment of dermatological condition caused by antimicrobial skin infections.

The present invention relates to the controlled release oral pharmaceutical compositions comprising Brivaracetam or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients, where in the pharmaceutical composition is used for the treatment of partial-onset seizures. ...

A topical pharmaceutical composition containing Crisaborole or its pharmaceutically acceptable salts, one or more suitable carrier to manufacture an ointment, which is intended to be used for the treatment of Atopic dermatitis.

The present invention relates to a topical pharmaceutical composition in specific a lotion composition containing a pyridonecarboxylic acid derivative or a pharmaceutically acceptable salt thereof, having an antimicrobial activity, which is effective for treatment of superficial skin infections and acne accompanied ...

The present invention relates to a pharmaceutical composition comprising Eltrombopag Olamine and two or more diluents wherein first diluent is less than 25% and the process of preparing the pharmaceutical composition. The pharmaceutical composition is used in the treatment of prophylaxis of immune (idiopathic) throm...

The present invention relates to the immediate release tablet oral dosage form of Sacubitril; Valsartan or its pharmaceutically acceptable salts thereof, more particularly, the present invention relates to a composition comprising trisodium salt of Sacubitril-valsartan complex and one or more pharmaceutically accept...

The present invention relates to the extended release tablet oral dosage form of Upadacitinib or its pharmaceutically acceptable salts thereof, processes for the preparing of Upadacitinib, at least one or more complexing agent and one or more pharmaceutically acceptable excipients free of diluent and optionally acid...

The present invention relates to a pharmaceutical composition comprising solid dispersion of Lumateperone or its pharmaceutically acceptable salt thereof, at least one polymer and one or more pharmaceutically acceptable excipients. The present invention further relates to methods of preparing and administering such ...

The present invention relates to oral pharmaceutical compositions comprising Dapagliflozin or its pharmaceutically acceptable salts thereof alone or its combination with Metformin or its salts, one or more pharmaceutically acceptable excipients. Where in the Metformin is in the form of immediate release or extended ...

The present invention is to provide a solid dispersion (Premix) of Upadacitinib or its pharmaceutically acceptable salts thereof with at least one or more pharmaceutically acceptable excipient and the present invention further provides an extended release pharmaceutical composition using Upadacitinib premix and at l...

The present invention relates to oral pharmaceutical composition comprising Lumateperone or pharmaceutically acceptable salt thereof. The present invention further relates to methods of preparing and administering such pharmaceutical compositions for treating central nervous system disorders selected from schizophre...

The present invention relates to oral pharmaceutical composition comprising Lumateperone or pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients, wherein the composition comprising sugar alcohol at least 60%. The present invention further relates to methods of preparing and administerin...

The present invention relates to oral stable pharmaceutical composition comprising Eltrombopag or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient; wherein the particle size D90 or d (0.9) of the Eltrombopag is greater than 95 microns and the disintegrant in an amount of...

The present invention relates to oral stable pharmaceutical composition comprising Eltrombopag or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient; wherein the particle size D90 or d(0.9) of the Eltrombopag is less than 10 microns and the disintegrant is present in an am...

The present invention relates to a pharmaceutical composition comprising a solid dispersion of Finerenone or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients, process for preparation of pharmaceutical composition comprising solid dispersion of Finerenone. ...

TITLE: “PHARMACEUTICAL COMPOSITIONS OF IPRAGLIFLOZIN” The present invention relates to a pharmaceutical compositions comprising Ipragliflozin or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients, processes for the preparation of the pharmaceutical composition. ...

The present invention relates to a pharmaceutical compositions comprising Finerenone or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients, processes for the preparation of the pharmaceutical composition.

The present invention relates to extended release tablet oral composition comprising Upadacitinib or its pharmaceutically acceptable salts and one or more pharmaceutically acceptable excipients thereof.

The present invention relates to bilayer tablet composition comprising of extended release and delayed release portions of Upadacitinib or its pharmaceutically acceptable salts thereof, and process for the preparing of formulation comprising Upadacitinib bilayer tablet composition with Upadacitinib and one or more p...

The present invention relates to a bilayer tablet composition comprising immediate release and extended release layered composition of Upadacitinib in a single pharmaceutical dosage form comprising Upadacitinib and its acceptable salts thereof, processes for the preparing and one or more pharmaceutically acceptable ...

The present invention relates to the oral pharmaceutical compositions comprising Bempedoic acid, Ezetimibe and Atorvastatin or its pharmaceutical acceptable salts thereof and one or more pharmaceutically acceptable excipients, wherein the oral pharmaceutical composition is a bilayer tablet composition, which is suit...

The present invention relates to the oral pharmaceutical compositions comprising Bempedoic acid, Ezetimibe and Rosuvastatin or its pharmaceutical acceptable salts thereof and one or more pharmaceutically acceptable excipients, wherein the oral pharmaceutical composition is a bilayer tablet composition, which is suit...

The present invention relates to the immediate release tablet oral dosage form of Sacubitril; Valsartan or its pharmaceutically acceptable salts thereof, more particularly, the present invention relates to the composition comprising crystalline Form P of trisodium hydrate of Sacubitril; Valsartan complex and one or ...

The present invention relates to stable topical compositions comprising Tofacitinib or pharmaceutically acceptable salt thereof and optionally one or more pharmaceutical excipients. The present invention further relates to methods of preparing and administering such pharmaceutical compositions for treating Janus kin...

The present invention relates to a pharmaceutical composition comprising a solid dispersion of Sacubitril; Valsartan trisodium complex with pharmaceutically acceptable carrier, process for preparation of pharmaceutical composition comprising solid dispersion of Sacubitril; Valsartan trisodium complex and administrat...

The present invention relates to the immediate release tablet oral dosage form of Sacubitril; Valsartan or its pharmaceutically acceptable salts thereof, more particularly, the present invention relates to composition comprising tri sodium hemi pentahydrate of sacubitril-valsartan complex and one or more pharmaceuti...

The present invention relates to the pharmaceutical dosage form of Sacubitril & Valsartan complex and SGLT2 inhibitor or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients, Furthermore the invention is directed to said pharmaceutical combination for use in the preven...

The present invention relates to a process for preparation of Bempedoic Acid and Ezetimibe composition, where in the said composition comprising of Bempedoic Acid or its salts and Ezetimibe or pharmaceutically acceptable salt and one or more pharmaceutically acceptable excipient. The present invention further relate...

The present invention relates to an extended release pharmaceutical composition comprising Linagliptin or its pharmaceutically acceptable salt thereof combination with Metformin or its salt with stabilizing agent and one or more pharmaceutically acceptable excipients, where in the composition is used for the treatme...

The present invention relates to an oral pellet pharmaceutical composition comprising Tafamidis or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients wherein the composition is used for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-medi...

The present invention relates to the oral pharmaceutical compositions comprising Dapagliflozin or its salts, Linagliptin or its salts thereof alone or combination with Metformin or its pharmaceutically acceptable salts, with one or more pharmaceutically acceptable excipients, wherein the Metformin is in the form of ...

The present invention relates to an oral pharmaceutical composition comprising Tafamidis or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients wherein the composition is in the form of granule/pellets/powder filled in capsules. Wherein the composition is used for the...

The present invention relates to a process for preparation of Solifenacin composition, where in the process involves the dispersion of Solifenacin in the binder solution, the said composition comprising of Solifenacin or pharmaceutically acceptable salt and one or more pharmaceutically acceptable excipient, the pres...

The present invention relates to a pharmaceutical composition comprising Roxadustat or its pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable excipients, processes for the preparation of the pharmaceutical composition. where in the composition is used for the treatment of the sympt...

The present invention relates to a pharmaceutical compositions comprising a SLGT2 inhibitor or its pharmaceutically acceptable salts in combination with DPP-IV inhibitor further comprising of any other anti-diabetic agent or its pharmaceutically acceptable salts and one or more excipients, use of the pharmaceutical ...

Title: “MULTI LAYERED FORMULATION AND PROCESS OF PREPARATION THEREOF” The present invention relates to a multi-layered dosage form comprising combination of potassium-competitive acid blockers (PCAB) inhibitors or proton-pump inhibitor and prokinetic agents more particularly to a multi-layer formulation comprising ...